Management of Hepatic Encephalopathy with Rifaximin and Polyethylene Glycol (PEG) 3350

被引：0
|
作者：
Gaddis, Amy [1 ]
Howard, Tammi [1 ]
Kemmer, Nyingi [1 ]
Hernandez, Maria [1 ]
Kaiser, Tiffany [1 ]
Neff, Guy [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷
关键词：
D O I：
10.14309/00000434-201010001-00272
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
272
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [31] Rifaximin (Xifaxan 550) for Hepatic Encephalopathy
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1350): : 87 - 87
  • [32] Less Recurrence of hepatic Encephalopathy with Rifaximin
    Jager-Becker, Dagmar
    VISCERAL MEDICINE, 2020, 36 (03) : 253 - 253
  • [33] RIFAXIMIN: A NONSYSTEMIC ANTIBIOTIC FOR HEPATIC ENCEPHALOPATHY
    Welliver, Mark
    GASTROENTEROLOGY NURSING, 2013, 36 (02) : 140 - 142
  • [34] Letter: the effects of rifaximin in hepatic encephalopathy
    Dai, C.
    Jiang, M.
    Sun, M. -J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (07) : 857 - 858
  • [35] Rifaximin and nonabsorbable disaccharides for hepatic encephalopathy
    Guslandi, Mario
    Cella, Alessandra
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (03) : 376 - 376
  • [36] Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy
    Neff, G. W.
    Kemmer, N.
    Zacharias, V. C.
    Kaiser, T.
    Duncan, C.
    McHenry, R.
    Jonas, M.
    Novick, D.
    Williamson, C.
    Hess, K.
    Thomas, M.
    Buell, J.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (10) : 3552 - 3555
  • [37] PEG 3350 Administration Is Not Associated with Sustained Elevation of Glycol Levels
    Williams, Kent C.
    Rogers, Lynette K.
    Hill, Ivor
    Barnard, John
    Di Lorenzo, Carlo
    JOURNAL OF PEDIATRICS, 2018, 195 : 148 - +
  • [38] Polyethylene glycol 3350 for constipation in children with dysfunctional elimination
    Erickson, BA
    Austin, JC
    Cooper, CS
    Boyt, MA
    JOURNAL OF UROLOGY, 2003, 170 (04): : 1518 - 1520
  • [39] Long-term efficacy and safety of polyethylene glycol 3350 (PEG) for the treatment of chronic constipation and encopresis in children
    Pashankar, DS
    Loening-Baucke, V
    Bishop, WP
    GASTROENTEROLOGY, 2002, 122 (04) : A318 - A318
  • [40] Efficacy and optimal dose of daily polyethylene glycol 3350 (PEG) for treatment of chronic constipation and encopresis in children.
    Bishop, WP
    Pashankar, D
    GASTROENTEROLOGY, 2001, 120 (05) : A754 - A754
12345